Today we present 28 new placebo and nocebo research papers, book chapters, comments and abstracts identified during September 2022. As usual, they are based on new PUBMED publication using the search terms „placebo“ and „nocebo“ and are hand-selected from more than 1105 new publications during the preceding month. Previously published monthly updates can be found in our archive. Todays selection as well as all previously identified papers will also go into our placebo research library that currently contains nearly 5,000 relevant papers. If you would like to get access to the full database, please register for our newsletter and provide us with your email address and affiliation.
Benedetti, F. (2022).
Historical evolution of the scientific investigation of the placebo analgesic effect. Front Pain Res, 3, 961304. doi:10.3389/fpain.2022.961304
https://www.ncbi.nlm.nih.gov/pubmed/36034753
Benedetti, F., Shaibani, A., Arduino, C., & Thoen, W. (2022).
Open-label nondeceptive placebo analgesia is blocked by the opioid antagonist naloxone. Pain. doi:10.1097/j.pain.0000000000002791
https://www.ncbi.nlm.nih.gov/pubmed/36165878
Bosman, M., Smeets, F., Elsenbruch, S., Tack, J., Simren, M., Talley, N., Winkens, B., Masclee, A. & Keszthelyi, D. (2022).
Placebo response in pharmacological trials in patients with functional dyspepsia – A systematic review and meta-analysis. Neurogastroenterol Motil, e14474. doi:10.1111/nmo.14474
https://www.ncbi.nlm.nih.gov/pubmed/36168188
Chin, Y. H., Lim, O., Lin, C., Chan, Y. Y., Kong, G., Ng, C. H., Chong, B., Syn, N., Chan, K. E., Muthiah, M. D., Siddiqui, M. S., Wang, J. W., Figtree, G., Chan, M. Y. & Chew, N. W. S. (2022).
Meta-analysis of the Placebo and Nocebo Effects Associated with Placebo Treatment in Randomized Trials of Lipid Lowering Therapy. Eur Heart J Qual Care Clin Outcomes. doi:10.1093/ehjqcco/qcac060
https://www.ncbi.nlm.nih.gov/pubmed/36107462
Cornell, J., Taj, A., Sivinski, J., Yin, M., Bhatia, P., Oula, D., Fatschel, S., Franklin, P., Noel, J., Colloca, L. & Seneviratne, C. (2022).
Integration of virtual platforms for enhanced conference experience: Data-based evidence from the Society of Interdisciplinary Placebo Studies 2021 conference. Front Commun, 7. doi:10.3389/fcomm.2022.857661
https://www.ncbi.nlm.nih.gov/pubmed/36081878
Di Stefano, M., Brondino, N., Bonaso, V., Miceli, E., Lapia, F., Grandi, G., Pagani, E., Corazza, G. R. & Di Sabatino, A. (2022).
The Perception of Lactose-Related Symptoms of Patients with Lactose Malabsorption. Int J Environ Res Public Health, 19(16). doi:10.3390/ijerph191610234
https://www.ncbi.nlm.nih.gov/pubmed/36011869
Druart, L., Vauthrin, O., Pinsault, N., Locher, C., & Blease, C. (2022).
‘It’s not my greengrocer, it’s someone from the medical profession’: A qualitative study regarding acceptability of deceptive and open-label placebo prescribing in France. Br J Health Psychol. doi:10.1111/bjhp.12624
https://www.ncbi.nlm.nih.gov/pubmed/36086862
Fiorio, M., Braga, M., Marotta, A., Villa-Sanchez, B., Edwards, M. J., Tinazzi, M., & Barbiani, D. (2022).
Functional neurological disorder and placebo and nocebo effects: shared mechanisms. Nat Rev Neurol, 18(10), 624-635. doi:10.1038/s41582-022-00711-z
https://www.ncbi.nlm.nih.gov/pubmed/36075980
Goyal, R. K., Kalaria, S. N., McElroy, S. L., & Gopalakrishnan, M. (2022).
An exploratory machine learning approach to identify placebo responders in pharmacological binge eating disorder trials. Clin Transl Sci. doi:10.1111/cts.13406
https://www.ncbi.nlm.nih.gov/pubmed/36126231
Hartmann, H., Forbes, P. A. G., Rutgen, M., & Lamm, C. (2022).
Placebo Analgesia Reduces Costly Prosocial Helping to Lower Another Person’s Pain. Psychol Sci, 9567976221119727. doi:10.1177/09567976221119727
https://www.ncbi.nlm.nih.gov/pubmed/36173691
Kube, T., Kirsch, I., Glombiewski, J. A., & Herzog, P. (2022).
Can placebos reduce intrusive memories? Behav Res Ther, 158, 104197. doi:10.1016/j.brat.2022.104197
https://www.ncbi.nlm.nih.gov/pubmed/36122440
Meeuwis, S. H., Skvortsova, A., van Laarhoven, A. I. M., Holle, H., & Evers, A. W. M. (2022). Can contagious itch be affected by positive and negative suggestions? Exp Dermatol. doi:10.1111/exd.14663
https://www.ncbi.nlm.nih.gov/pubmed/36048562
Meijers, M. C., Stouthard, J., Evers, A. W. M., Das, E., Drooger, H. J., Jansen, S., Francke, A. L., Plum, N., van der Wall, E., Nestoriuc, Y., Dusseldorp, E. & van Vliet, L. M. (2022).
Possible alleviation of symptoms and side effects through clinicians’ nocebo information and empathy in an experimental video vignette study. Sci Rep, 12(1), 16112. doi:10.1038/s41598-022-19729-w
https://www.ncbi.nlm.nih.gov/pubmed/36167876
Michnevich, T., Pan, Y., Hendi, A., Oechsle, K., Stein, A., & Nestoriuc, Y. (2022).
Preventing adverse events of chemotherapy for gastrointestinal cancer by educating patients about the nocebo effect: a randomized-controlled trial. BMC Cancer, 22(1), 1008. doi:10.1186/s12885-022-10089-2
https://www.ncbi.nlm.nih.gov/pubmed/36138381
Muench, A., Giller, J., Morales, K. H., Culnan, E., Khader, W., Kaptchuk, T. J., McCall, W. V. & Perlis, M. L. (2022).
Do Placebos Primarily Affect Subjective as Opposed to Objective Measures? A Meta-Analysis of Placebo Responses in Insomnia RCTs. Behav Sleep Med, 1-13. doi:10.1080/15402002.2022.2115046
https://www.ncbi.nlm.nih.gov/pubmed/36094215
Oakley, T., Coskuner, J., Cadwallader, A., Ravan, M., & Hasey, G. (2022).
EEG Biomarkers to Predict Response to Sertraline and Placebo Treatment in Major Depressive Disorder. IEEE Trans Biomed Eng, PP. doi:10.1109/TBME.2022.3204861
https://www.ncbi.nlm.nih.gov/pubmed/36094967
Parong, J., Seitz, A. R., Jaeggi, S. M., & Green, C. S. (2022).
Expectation effects in working memory training. Proc Natl Acad Sci U S A, 119(37), e2209308119. doi:10.1073/pnas.2209308119
https://www.ncbi.nlm.nih.gov/pubmed/36067292
Rooney, T., Sharpe, L., Todd, J., Richmond, B., & Colagiuri, B. (2022).
The relationship between expectancy, anxiety, and the nocebo effect: a systematic review and meta-analysis with recommendations for future research. Health Psychol Rev, 1-28. doi:10.1080/17437199.2022.2125894
https://www.ncbi.nlm.nih.gov/pubmed/36111435
Rosenkjaer, S., Lunde, S. J., Kirsch, I., & Vase, L. (2022).
Expectations: How and when do they contribute to placebo analgesia? Front Psychiatry, 13, 817179. doi:10.3389/fpsyt.2022.817179
https://www.ncbi.nlm.nih.gov/pubmed/36147975
Roustit, M., Jullien, A., Jambon-Barbara, C., Goudon, H., Blaise, S., Cracowski, J. L., & Khouri, C. (2022).
Placebo response in Raynaud’s Phenomenon clinical trials: The prominent role of regression towards the mean: Placebo response in Raynaud’s Phenomenon. Semin Arthritis Rheum, 57, 152087. doi:10.1016/j.semarthrit.2022.152087
https://www.ncbi.nlm.nih.gov/pubmed/36088751
Russell, K., Duncan, M., Price, M., Mosewich, A., Ellmers, T., & Hill, M. (2022).
A comparison of placebo and nocebo effects on objective and subjective postural stability: a double-edged sword? Front Hum Neurosci, 16, 967722. doi:10.3389/fnhum.2022.967722
https://www.ncbi.nlm.nih.gov/pubmed/36061498
Seneviratne, C., Noel, J., Franklin, P. D., & Colloca, L. (2022).
Editorial: Harnessing placebo mechanisms. Front Psychiatry, 13, 1022762. doi:10.3389/fpsyt.2022.1022762
https://www.ncbi.nlm.nih.gov/pubmed/36172509
Wang, Y. B., Guo, L., Fan, J. Y., & Mao, Z. X. (2022).
Expectations Come True: The Placebo Effect of Exercise on Affective Responses. Res Q Exerc Sport, 1-9. doi:10.1080/02701367.2022.2121372
https://www.ncbi.nlm.nih.gov/pubmed/36121715
Watanabe, Y., Nishimura, A., Kikuchi, T., Sawada, N., Imazaki, M., Inada, I., & Watanabe, K. (2022).
Central monitoring of depression and anxiety symptoms reduces placebo responses in depression clinical trials: A post hoc exploratory analysis of data from the phase III CCT-004 trial of vortioxetine. Neuropsychopharmacol Rep. doi:10.1002/npr2.12288
https://www.ncbi.nlm.nih.gov/pubmed/36151855
Wong, E. C. L., Dulai, P. S., Marshall, J. K., Jairath, V., Reinisch, W., & Narula, N. (2022).
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis. Clin Gastroenterol Hepatol. doi:10.1016/j.cgh.2022.08.015
https://www.ncbi.nlm.nih.gov/pubmed/36029969
Yennurajalingam, S., Azhar, A., Lu, Z., Rodriguez, A. J., Arechiga, A. B., Guerra-Sanchez, M., Stanton, P., Andersen, C. R., Urbauer, D. L. & Bruera, E. (2022).
Open-Label Placebo for the Treatment of Cancer-Related Fatigue in Patients with Advanced Cancer: A Randomized Controlled Trial. Oncologist. doi:10.1093/oncolo/oyac184
https://www.ncbi.nlm.nih.gov/pubmed/36106759
Zech, N., Schrodinger, M., & Hansen, E. (2022).
Avoidance of nocebo effects by coincident naming of treatment benefits during the medical interview for informed consent-Evidence from dynamometry. Front Psychol, 13, 923044. doi:10.3389/fpsyg.2022.923044
https://www.ncbi.nlm.nih.gov/pubmed/36017426
Zunhammer, M., Goltz, G., Schweifel, M., Stuck, B. A., & Bingel, U. (2022).
Savor the flavor: A randomized double-blind study assessing taste-enhanced placebo analgesia in healthy volunteers. Clin Transl Sci. doi:10.1111/cts.13397
https://www.ncbi.nlm.nih.gov/pubmed/36088659
Download PDF here.